Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 and LIN-MD-64 completers)

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Irritable Bowel Syndrome With Constipation

Drug Information

Target Indication

Irritable Bowel Syndrome With Constipation

Clinical Trial

Last updated: 1/9/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

ABBV

AbbVie Inc.

Related Pipeline

Chronic Lymphocytic Leukemia

Open-Angle Glaucoma

Moderate to Severe Plaque Psoriasis

Multiple Myeloma

Polycystic Ovary Syndrome

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts